長期投資家のためのIR情報
バリュートレンド

【4557】医学生物学研究所 〔上場廃止〕
臨床検査薬・研究用試薬。親会社はJSR。
類似企業:

売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2021.03 2020/10/27 Q2予 9,700 ↑ +3.7% +3.7% 1,800 ↑ +20.0% +20.0% 1,800 ↑ +16.1% +16.1% 1,550 ↑ +24.0% +24.0%
2021.03 2020/07/28 Q1予 9,350 → 0.0% 0.0% 1,500 → 0.0% 0.0% 1,550 → 0.0% 0.0% 1,250 → 0.0% 0.0%
2021.03 2020/04/28 当初予 9,350 - - - 1,500 - - - 1,550 - - - 1,250 - - -
2020.03 2020/04/28 実 9,229 ↓ -0.8% +7.3% 1,334 ↓ -4.7% +33.4% 1,326 ↑ +2.0% +32.6% 1,266 ↑ +5.5% +48.9%
2020.03 2020/03/31 修正予 9,300 → 0.0% +8.1% 1,400 → 0.0% +40.0% 1,300 → 0.0% +30.0% 1,200 ↑ +9.1% +41.2%
2020.03 2020/01/28 Q3予 9,300 → 0.0% +8.1% 1,400 → 0.0% +40.0% 1,300 → 0.0% +30.0% 1,100 → 0.0% +29.4%
2020.03 2019/10/29 修正予 9,300 ↑ +8.1% +8.1% 1,400 ↑ +40.0% +40.0% 1,300 ↑ +30.0% +30.0% 1,100 ↑ +29.4% +29.4%
2020.03 2019/07/30 Q1予 8,600 → 0.0% 0.0% 1,000 → 0.0% 0.0% 1,000 → 0.0% 0.0% 850 → 0.0% 0.0%
2020.03 2019/04/23 当初予 8,600 - - - 1,000 - - - 1,000 - - - 850 - - -
2019.03 2019/04/23 実 8,182 ↑ +1.0% +7.7% 488 ↑ +22.0% +112.2% 552 ↑ +31.4% +224.7% 316 ↑ +97.5% +110.7%
2019.03 2019/03/28 修正予 8,100 ↑ +6.6% +6.6% 400 ↑ +73.9% +73.9% 420 ↑ +147.1% +147.1% 160 ↑ +362.3% +6.7%
2019.03 2019/01/29 Q3予 7,600 → 0.0% 0.0% 230 → 0.0% 0.0% 170 → 0.0% 0.0% -61 → 0.0% -140.7%
2019.03 2018/11/16 修正予 7,600 → 0.0% 0.0% 230 → 0.0% 0.0% 170 → 0.0% 0.0% -61 ↓ -140.7% -140.7%
2019.03 2018/10/30 Q2予 7,600 → 0.0% 0.0% 230 → 0.0% 0.0% 170 → 0.0% 0.0% 150 → 0.0% 0.0%
2019.03 2018/07/31 Q1予 7,600 → 0.0% 0.0% 230 - - - 170 → 0.0% 0.0% 150 → 0.0% 0.0%
2019.03 2018/04/24 当初予 7,600 - - - - - - - 170 - - - 150 - - -
2018.03 2018/04/24 実 - - - - - - - - - - - - - - - -
2018.03 2018/04/20 修正予 7,072 ↓ -0.4% -0.4% - - - - 11 ↑ +155.0% +106.5% -59 ↑ +41.0% +68.8%
2018.03 2018/01/30 修正予 7,100 → 0.0% 0.0% 50 → 0.0% 0.0% -20 ↑ +88.2% +88.2% -100 ↑ +47.1% +47.1%
2018.03 2017/10/27 Q2予 7,100 → 0.0% 0.0% 50 → 0.0% 0.0% -170 → 0.0% 0.0% -189 → 0.0% 0.0%
2018.03 2017/07/25 Q1予 7,100 → 0.0% 0.0% 50 → 0.0% 0.0% -170 → 0.0% 0.0% -189 → 0.0% 0.0%
2018.03 2017/04/25 当初予 7,100 - - - 50 - - - -170 - - - -189 - - -
2017.03 2017/04/25 実 7,348 → 0.0% -1.1% 85 → 0.0% - 64 → 0.0% +146.2% 188 → 0.0% -36.7%
2017.03 2017/04/20 修正予 7,348 ↓ -1.1% -1.1% 85 ↑ - - 64 ↑ +146.2% +146.2% 188 ↓ -36.7% -36.7%
2017.03 2017/01/24 Q3予 7,430 → 0.0% 0.0% 0 → - - 26 → 0.0% 0.0% 297 → 0.0% 0.0%
2017.03 2016/10/28 Q2予 7,430 → 0.0% 0.0% 0 → - - 26 → 0.0% 0.0% 297 → 0.0% 0.0%
2017.03 2016/04/28 当初予 7,430 - - - 0 - - - 26 - - - 297 - - -
2016.03 2016/04/28 実 8,056 → 0.0% -11.3% -368 ↓ -4.8% -417.2% -449 ↓ -0.4% -497.3% -1,142 ↑ +1.3% -1412.6%
2016.03 2016/04/19 修正予 8,056 ↓ -0.5% -11.3% -351 ↓ -8.3% -402.6% -447 ↓ -25.2% -495.6% -1,157 ↑ +3.6% -1429.9%
2016.03 2016/02/16 修正予 8,093 ↓ -10.9% -10.9% -324 ↓ -379.3% -379.3% -357 ↓ -415.9% -415.9% -1,200 ↓ -1479.3% -1479.3%
2016.03 2016/01/26 Q3予 9,086 → 0.0% 0.0% 116 → 0.0% 0.0% 113 → 0.0% 0.0% 87 → 0.0% 0.0%
2016.03 2015/10/26 Q2予 9,086 → 0.0% 0.0% 116 → 0.0% 0.0% 113 → 0.0% 0.0% 87 → 0.0% 0.0%
2016.03 2015/07/27 Q1予 9,086 → 0.0% 0.0% 116 - - - 113 → 0.0% 0.0% 87 → 0.0% 0.0%
2016.03 2015/04/27 当初予 9,086 - - - - - - - 113 - - - 87 - - -
2015.03 2015/04/27 実 - - - - - - - - - - - - - - - -
2015.03 2015/01/26 Q3予 7,773 → 0.0% -1.0% -789 → 0.0% -558.7% -680 → 0.0% -569.0% -754 → 0.0% -693.7%
2015.03 2015/01/09 修正予 7,773 ↓ -1.0% -1.0% -789 ↓ -558.7% -558.7% -680 ↓ -569.0% -569.0% -754 ↓ -693.7% -693.7%
2015.03 2014/10/27 Q2予 7,854 → 0.0% 0.0% 172 → 0.0% 0.0% 145 → 0.0% 0.0% 127 → 0.0% 0.0%
2015.03 2014/07/29 Q1予 7,854 → 0.0% 0.0% 172 → 0.0% 0.0% 145 → 0.0% 0.0% 127 → 0.0% 0.0%
2015.03 2014/05/02 当初予 7,854 - - - 172 - - - 145 - - - 127 - - -
2014.03 2014/05/02 実 7,172 → 0.0% -2.8% -519 → 0.0% -88.7% -476 → 0.0% -157.3% -418 → 0.0% -216.7%
2014.03 2014/04/21 修正予 7,172 ↓ -2.8% -2.8% -519 ↓ -88.7% -88.7% -476 ↓ -157.3% -157.3% -418 ↓ -216.7% -216.7%
2014.03 2014/01/31 当初予 7,378 - - - -275 - - - -185 - - - -132 - - -
シェア ツイート
ページトップへ戻る